Framework for the Supply of Radiopharmaceuticals and Related Consumables 2023
HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.
Buyer
HealthTrust Europe LLP (HTE) acting on behalf of
Value
£100,000,000
Published
26 May 2023
Closes
7 Jul 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
09344000
Radio-isotopes
Lots
Lot default Framework for the Supply of Radiopharmaceuticals and Related Consumables 2023
£100,000,000
HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases. The duration of the framework agreement will be two (2) years initial period with the option of extending for...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
26 May 2023
Opportunity notice on Contracts Finder
Tender notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.